论文部分内容阅读
目的研究早期应用小剂量多巴胺联合呋塞米治疗心力衰竭患者的临床疗效。方法 138例心力衰竭Ⅲ-Ⅳ级患者随机分为治疗组和对照组,各69例,在心力衰竭常规治疗基础上,治疗组采用早期小剂量多巴胺联合呋塞米治疗,对照组单用呋塞米治疗,比较两组患者心功能改善情况。结果治疗组总有效率高于对照组,比较差异有统计学意义(χ2=10.66,P<0.05)。治疗组患者平均住院时间(5.24±1.17)d,对照组平均住院时间(7.96±1.23)d,治疗组平均住院时间比对照组少,比较差异有统计学意义(t=6.32,P<0.05)。结论早期应用小剂量多巴胺联合呋塞米治疗心力衰竭对心功能改善疗效优于单用呋塞米治疗,值得临床推广应用。
Objective To study the early clinical application of low dose dopamine combined with furosemide in patients with heart failure. Methods A total of 138 patients with grade Ⅲ-Ⅳ heart failure were randomly divided into treatment group and control group, with 69 cases in each. On the basis of conventional treatment of heart failure, the treatment group was treated with early small dose of dopamine combined with furosemide, M treatment, compared two groups of patients to improve cardiac function. Results The total effective rate of the treatment group was higher than that of the control group, with significant difference (χ2 = 10.66, P <0.05). The average length of hospital stay in the treatment group (5.24 ± 1.17) d and the control group (7.96 ± 1.23) d, and the average length of stay in the treatment group were less than those in the control group (t = 6.32, P <0.05) . Conclusion Early application of low-dose dopamine combined with furosemide in the treatment of heart failure is superior to single-use furosemide in improving cardiac function, which is worthy of clinical application.